Case Report on a Patient with Steinert Disease Complicated by COVID-19

Roberto Chalela, 1– 4 Oswaldo Caguana, 1, 2 Flavio Zuccarino, 5 Karys Khilzi, 1, 2 Diego A Rodríguez-Chiaradía 1– 4 1Respiratory Medicine Department, Hospital del Mar, Barcelona, Spain; 2Institut Hospital del Mar d’Investigacions Mèdiq...

Full description

Bibliographic Details
Main Authors: Chalela R, Caguana O, Zuccarino F, Khilzi K, Rodríguez-Chiaradía DA
Format: Article
Language:English
Published: Dove Medical Press 2020-11-01
Series:Vascular Health and Risk Management
Subjects:
Online Access:https://www.dovepress.com/case-report-on-patients-with-steinert-disease-complicated-by-covid-19-peer-reviewed-article-VHRM
Description
Summary:Roberto Chalela, 1– 4 Oswaldo Caguana, 1, 2 Flavio Zuccarino, 5 Karys Khilzi, 1, 2 Diego A Rodríguez-Chiaradía 1– 4 1Respiratory Medicine Department, Hospital del Mar, Barcelona, Spain; 2Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain; 3Universitat Pompeu Fabra, Barcelona, Spain; 4Centro de Investigación en Red de Enfermedades Respiratorias(CIBERES), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; 5Department of Radiology, Hospital del Mar, Barcelona, SpainCorrespondence: Diego A Rodríguez-ChiaradíaRespiratory Medicine Department, Hospital del Mar, Passeig Maritim, 25, Barcelona, 08003, SpainTel +34 932483548Email DARodriguez@parcdesalutmar.catAbstract: SARS-CoV-2 infection is predominantly a respiratory disease with a diverse clinical spectrum. Pulmonary thromboembolic complications during COVID-19 pneumonia may be associated with a high mortality rate and post-mortem findings confirm the presence of platelet-fibrin thrombi in arterial vessels of patients together with lung tissue alterations. We present a patient transferred to the emergency department due to a syncope with no other associated symptoms, who was diagnosed with an acute pulmonary embolism (PE) concomitant with SARS-CoV-2 infection without lung infiltrates. Presenting with a PE as the only manifestation of this infection, reinforces our conception of COVID-19 as a heterogeneous disease of which we still know very little. We believe that while the virus is still circulating in our environment, we need to consider ruling out COVID-19 in all thrombotic events, even if the patients have no other risk factors.Keywords: COVID-19, SARS-CoV-2, pulmonary embolism, syncope, pandemic
ISSN:1178-2048